No black box warning on record for Inflectra

As of the latest FDA labeling reviewed, Inflectra (INFLIXIMAB-DYYB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Inflectra medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious infections – do not give INFLECTRA during an active infection. If an infection develops, monitor carefully and stop INFLECTRA if infection becomes serious. ( 5.1 ) • Invasive fungal infections – for patients who develop a systemic illness on INFLECTRA, consider empiric antifungal therapy for those who reside or travel to regions where mycoses are endemic. ( 5.1

No black box warning on record for Inflectra

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious infections – do not give INFLECTRA during an active infection. If an infection develops, monitor carefully and stop INFLECTRA if infection becomes serious. ( 5.1 ) • Invasive fungal infections – for patients who develop a systemic illness on INFLECTRA, consider empiric antifungal therapy for those who reside or travel to regions where mycoses are endemic. ( 5.1

Inflectra Black Box Warning

No black box warning on record for Inflectra

Other warnings & precautions

Inflectra Black Box Warning

No black box warning on record for Inflectra

Other warnings & precautions